GLP-1 medications have been extensively studied and are FDA-approved for weight loss
Taking into account the above-mentioned considerations on cost and safety aspects, oral small molecule agonists stimulating endogenous GLP-1 secretion by intestinal L-cells may offer a promising alternative for developing new treatments for Type 2 diabetes and obesity
This, this just eat less, move more mentality can lead to eating disorders and is sometimes I see, I see people across the board, whether it's physicians, dieticians, uh, personal trainers
Results Among 97,255 patients from 55 centers, 67.4% agreed to be contacted for future research
The list price for Wegovy is $1,349.02 without discounts or rebates
Which approach is right, or whether each suits a different patient group, is an open question the field will not resolve quickly